Sagimet Biosciences Statistics
Total Valuation
SGMT has a market cap or net worth of $164.36 million. The enterprise value is -$17.92 million.
Important Dates
The next estimated earnings date is Monday, November 11, 2024, before market open.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SGMT has 31.91 million shares outstanding. The number of shares has increased by 13,667.47% in one year.
Shares Outstanding | 31.91M |
Shares Change (YoY) | +13,667.47% |
Shares Change (QoQ) | +9.90% |
Owned by Insiders (%) | 10.09% |
Owned by Institutions (%) | 42.51% |
Float | 16.20M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 68.37 |
Forward PS | n/a |
PB Ratio | 0.93 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 29.11, with a Debt / Equity ratio of 0.00.
Current Ratio | 29.11 |
Quick Ratio | 29.05 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.32% and return on invested capital (ROIC) is -22.70%.
Return on Equity (ROE) | -29.32% |
Return on Assets (ROA) | -21.54% |
Return on Capital (ROIC) | -22.70% |
Revenue Per Employee | $200,000 |
Profits Per Employee | -$2.93M |
Employee Count | 10 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.53% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +41.53% |
50-Day Moving Average | 3.92 |
200-Day Moving Average | 4.86 |
Relative Strength Index (RSI) | 56.34 |
Average Volume (20 Days) | 1,096,715 |
Short Selling Information
The latest short interest is 3.98 million, so 12.48% of the outstanding shares have been sold short.
Short Interest | 3.98M |
Short Previous Month | 1.97M |
Short % of Shares Out | 12.48% |
Short % of Float | 24.59% |
Short Ratio (days to cover) | 1.32 |
Income Statement
In the last 12 months, SGMT had revenue of $2.00 million and -$29.25 million in losses. Loss per share was -$1.14.
Revenue | 2.00M |
Gross Profit | 2.00M |
Operating Income | -36.28M |
Pretax Income | -27.92M |
Net Income | -29.25M |
EBITDA | n/a |
EBIT | -36.28M |
Loss Per Share | -$1.14 |
Full Income Statement Balance Sheet
The company has $166.37 million in cash and $153,000 in debt, giving a net cash position of $188.34 million or $5.90 per share.
Cash & Cash Equivalents | 166.37M |
Total Debt | 153,000 |
Net Cash | 188.34M |
Net Cash Per Share | $5.90 |
Equity (Book Value) | 183.29M |
Book Value Per Share | 5.74 |
Working Capital | 161.02M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -22.80M |
Capital Expenditures | n/a |
Free Cash Flow | -22.80M |
FCF Per Share | -$0.71 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -1,813.75% |
Pretax Margin | -1,462.55% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -1,144.50% |
Dividends & Yields
SGMT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13,667.47% |
Shareholder Yield | -13,667.47% |
Earnings Yield | -17.16% |
FCF Yield | -13.38% |
Analyst Forecast
The average price target for SGMT is $24.00, which is 366.02% higher than the current price. The consensus rating is "Buy".
Price Target | $24.00 |
Price Target Difference | 366.02% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 116.53% |
EPS Growth Forecast (5Y) | 13.57% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SGMT has an Altman Z-Score of 17.91 and a Piotroski F-Score of 2.
Altman Z-Score | 17.91 |
Piotroski F-Score | 2 |